Evidence map›Paper›PMID 40593585›Full record

ArticleNature communications2025

Enantioselective aza-electrophilic dearomatization of naphthalene derivatives.

Jun Liu, Haina Liu, Meijuan Zhou, Xiaolong Yu, Gang Zhao, Hongyu Wang

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Jun LiuKey Laboratory of Marine Drugs, Ministry of Education, Molecular Synthesis Center, and School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, P. R. China.
Haina LiuKey Laboratory of Marine Drugs, Ministry of Education, Molecular Synthesis Center, and School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, P. R. China.
Meijuan ZhouSDU-ANU Joint Science College, Shandong University, Weihai, 264209, P. R. China.
Xiaolong YuSDU-ANU Joint Science College, Shandong University, Weihai, 264209, P. R. China.
Gang ZhaoKey Laboratory of Fluorine and Nitrogen Chemistry and Advanced Materials, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 200032, P. R. China. zhaog@sioc.ac.cn.
Hongyu WangKey Laboratory of Marine Drugs, Ministry of Education, Molecular Synthesis Center, and School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, P. R. China. why@ouc.edu.cn.ORCID http://orcid.org/0000-0001-5720-6542

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21871282National Natural Science Foundation of China (National Science Foundation of China) 22301309National Natural Science Foundation of China (National Science Foundation of China) 22377113Taishan Scholar Foundation of Shandong Province tsqn202306026Taishan Scholar Foundation of Shandong Province tsqn202306103
6 · The paper itself

Abstract

The catalytic asymmetric dearomatization of naphthalenes is a pivotal strategy for generating enantioenriched three-dimensional aliphatic polycycles from flat aromatic precursors. However, achieving such transformations involving electronically unbiased naphthalenes remains a long-standing challenge. Here, we describe a silver-mediated enantioselective aza-electrophilic dearomatization approach that couples readily accessible vinylnaphthalenes in conjunction with azodicarboxylates to afford chiral polyheterocycles via formal [4 + 2] cycloaddition reactions, yielding up to 99% yield and 99 : 1 e.r. Central to the method is the formation of an aziridinium intermediate that facilitates the subsequent dearomatization of naphthalenes. A 100 mmol-scale reaction and the divergent transformation of the products into enantioenriched aliphatic polycycles highlight their synthetic utility. Mechanistic experiments and DFT calculations offer insights into the reaction mechanism and the origin of the observed enantiocontrol outcome.

Identifiers

PMID40593585
PMCPMC12218992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.